Compare Workday Inc (WDAY) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Workday Inc vs GeneDx Holdings Corp — how do they compare? Workday Inc trades at $186.52 (market cap $44.89B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). The key difference: Workday Inc is far larger — about 17.5× GeneDx Holdings Corp's market cap, and Workday Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| WDAY | WGS | |
|---|---|---|
Market Cap | $44.89B | $2.56B |
Sector | Technology | Technology |
52-Week High | $247.69 | $167.51 |
52-Week Low | $112.55 | $34.51 |
Enterprise Value | $45.26B | $2.60B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Workday (WDAY) trades at $186.28, down 4.86% today but has rallied 49.7% over three months on strong Q2 earnings beats and AI momentum. The stock shows bullish technical signals with support at $183 and resistance at $191. Fundamentally, revenue grew to $8.45B in 2025 with expanding margins, though valuation ratios remain elevated at P/E 37.94 and P/S 4.73. Recent news highlights Workday's eleventh consecutive leadership position in Gartner's HCM Magic Quadrant and growing AI adoption.
The outlook remains positive with analyst consensus at Buy (50.62%) and $204.52 price target, representing 9.8% upside. Key opportunities include AI-driven subscription growth and margin expansion, while risks involve competitive pressures from AI-native startups and execution challenges in sustaining profitability gains amid high valuations.
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
